{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:51:13Z","timestamp":1778694673602,"version":"3.51.4"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[1996,4,1]],"date-time":"1996-04-01T00:00:00Z","timestamp":828316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"NIH","award":["ROlAR3583707"],"award-info":[{"award-number":["ROlAR3583707"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The antiresorptive effects of calcitonin are well documented. Recent in vitro and in vivo evidence points to an anabolic effect of calcitonin on osteoblasts. To assess the value of calcitonin in preventing the rapid and early bone loss after cessation of ovarian function and to investigate its effects on osteoblasts in vivo, 32 dogs were ovariohysterectomized (OHX) and 32 dogs were sham-operated (Sham). After the surgeries, half of the OHX and Sham dogs received every-other-day subcutaneous injections of human calcitonin (0.25 mg\/dog\/d), and the remaining dogs were given vehicle. Half of the animals had a bone biopsy at week 2 and were euthanized thereafter; the other half of the animals underwent a bone biopsy at month 1 and were euthanized at month 4. Blood drawings were done at baseline and at the time of each bone biopsy. Calcitonin prevented the increase in erosion depth seen in OHX animals and prevented the cancellous bone loss observed at 2 weeks and at 1 and 4 months. Calcitonin did not affect bone volume in Sham dogs. However, treatment with calcitonin induced a decrease in mineralizing surfaces and bone formation rates at the bone surface and cell level and an increase in mineralization lag time in both Sham and OHX animals without significantly affecting osteoblast number. This finding indicates that the negative effect of calcitonin on bone mineralization is not solely the result of a decrease in bone turnover. The data show that calcitonin, because of its antiresorptive effects, can prevent bone loss after cessation of ovarian function. However, short-term treatment with calcitonin does not stimulate osteoblast activity; on the contrary, it exerts a negative effect on osteoblastic bone formation and mineralization. Long-term studies are needed to investigate whether this unwanted effect of calcitonin on osteoblasts in vivo represents a transitory or persistent phenomenon.<\/jats:p>","DOI":"10.1002\/jbmr.5650110405","type":"journal-article","created":{"date-parts":[[2010,2,3]],"date-time":"2010-02-03T15:32:17Z","timestamp":1265211137000},"page":"446-455","source":"Crossref","is-referenced-by-count":26,"title":["Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs"],"prefix":"10.1093","volume":"11","author":[{"given":"Marie-Claude","family":"Monier-Faugere","sequence":"first","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaopo","family":"Geng","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanle","family":"Qi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Illka","family":"Arnala","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut H.","family":"Malluche","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Bone and Mineral Metabolism, Department of Internal Medicine, University of Kentucky, Lexington, Kentucky, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1996,4,1]]},"reference":[{"key":"2024013114272464000_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/endo-70-5-638","article-title":"Evidence for calcitonin-a new hormone from the parathyroid that lowers blood calcium","volume":"70","author":"Copp","year":"1962","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(63)90224-1","article-title":"Further evidence for calcitonin-a rapid acting hormone which lowers plasma calcium","volume":"ii","author":"Kumar","year":"1963","journal-title":"Lancet"},{"key":"2024013114272464000_bib3","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.150.3702.1465","article-title":"Thyrocalcitonin, inhibitor of bone resorption in tissue culture","volume":"150","author":"Friedman","year":"1965","journal-title":"Science"},{"key":"2024013114272464000_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/endo-84-2-261","article-title":"Effect of calcitonin on the rates of bone formation and resorption in the rat","volume":"84","author":"Baylink","year":"1969","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1083\/jcb.60.2.346","article-title":"The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture","volume":"60","author":"Holtrop","year":"1974","journal-title":"J Cell Biol"},{"key":"2024013114272464000_bib6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1210\/jcem-47-1-184","article-title":"Calcitonin secretion in normal human subjects","volume":"47","author":"Parthemore","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013114272464000_bib7","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1073\/pnas.77.1.609","article-title":"Evidence for an important physiological role for calcitonin","volume":"77","author":"Talmage","year":"1980","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013114272464000_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198101293040505","article-title":"Calcitonin, physiology and pathophysiology","volume":"304","author":"Austin","year":"1981","journal-title":"N Engl J Med"},{"key":"2024013114272464000_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/path.1711360104","article-title":"Calcitonin alters behavior of isolated osteoclast","volume":"136","author":"Chambers","year":"1982","journal-title":"J Pathol"},{"key":"2024013114272464000_bib10","first-page":"237","author":"Agrawal","year":"1981"},{"key":"2024013114272464000_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0026-0495(84)90187-2","article-title":"Long-term calcitonin therapy in postmenopausal osteoporosis","volume":"33","author":"Gruber","year":"1984","journal-title":"Metabolism"},{"key":"2024013114272464000_bib12","first-page":"455","article-title":"Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in postmenopausal osteoporosis","volume":"38","author":"Gennari","year":"1985","journal-title":"Curr Ther Res"},{"key":"2024013114272464000_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0026-0495(85)90120-9","article-title":"Treatment of osteoporosis with calcitonin, with and without growth hormone","volume":"34","author":"Aloia","year":"1985","journal-title":"Metabolism"},{"key":"2024013114272464000_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02556587","article-title":"Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind study","volume":"38","author":"Mazzuoli","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1172\/JCI113725","article-title":"Bone turnover in postmenopausal osteoporosis (effect of calcitonin treatment)","volume":"82","author":"Civitelli","year":"1988","journal-title":"J Clin Invest"},{"key":"2024013114272464000_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF02556055","article-title":"Effect of calcitonin and vitamin D in osteoporosis","volume":"45","author":"Palmieri","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib17","first-page":"36","article-title":"Treatment of osteoporosis with salmon calcitonin-clinical experience with 100 patients","volume":"8","author":"Aloia","year":"1991","journal-title":"Adv Ther"},{"key":"2024013114272464000_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00297289","article-title":"Three-year calcitonin combination therapy for postmenopausal osteoporosis with crush fractures of the spine","volume":"50","author":"Sz\u00fccs","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib19","first-page":"S208","author":"Gennari","year":"1993"},{"key":"2024013114272464000_bib20","first-page":"155","article-title":"Side effects of synthetic salmon calcitonin given by intranasal spray compared with intramuscular injection","volume":"3","author":"Reginster","year":"1985","journal-title":"Clin and Exp Rheum"},{"key":"2024013114272464000_bib21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/bmj.299.6697.477","article-title":"Effect of salcatonin given intranasally on early postmenopausal bone loss","volume":"299","author":"Overgaard","year":"1989","journal-title":"Br Med J"},{"key":"2024013114272464000_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(90)90089-V","article-title":"Discontinuous calcitonin treatment of established osteoporosis-effects of withdrawal of treatment","volume":"89","author":"Overgaard","year":"1990","journal-title":"Am J Med"},{"issue":"suppl","key":"2024013114272464000_bib23","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1007\/BF02555091","article-title":"Long-term treatment of established osteoporosis with intranasal calcitonin","volume":"49","author":"Overgaard","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","article-title":"Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study","volume":"305","author":"Overgaard","year":"1992","journal-title":"BMJ"},{"key":"2024013114272464000_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00310161","article-title":"Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers","volume":"55","author":"Neilson","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0169-6009(92)90883-F","article-title":"Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome","volume":"16","author":"Rico","year":"1992","journal-title":"Bone Min"},{"key":"2024013114272464000_bib27","first-page":"400","volume-title":"Calcium Regulating Hormones and Bone Metabolism","author":"Gennari","year":"1992"},{"key":"2024013114272464000_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF02555225","article-title":"The effect of rectal and nasal administration of salmon calcitonin in normal subjects","volume":"47","author":"Buclin","year":"1987","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 1","key":"2024013114272464000_bib29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0169-6009(92)92032-L","article-title":"Effect of salmon calcitonin given by suppositories on bone mass in osteoporotic patients: a double blind placebo-controlled study","volume":"17","author":"Angelini","year":"1992","journal-title":"Bone Miner"},{"key":"2024013114272464000_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF00334545","article-title":"Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis","volume":"51","author":"Overgaard","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib31","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0140-6736(88)91712-6","article-title":"Calcitonin for prevention of postmenopausal bone loss","volume":"1","author":"McIntyre","year":"1988","journal-title":"Lancet"},{"key":"2024013114272464000_bib32","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(87)92619-5","article-title":"1-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin","volume":"ii","author":"Reginster","year":"1987","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2024013114272464000_bib33","first-page":"S162","article-title":"The role of intranasal calcitonin in the treatment and prophylaxis of postmenopausal osteoporosis (abstract)","volume":"3","author":"Overgaard","year":"1988","journal-title":"J Bone Min Res"},{"issue":"Suppl 1","key":"2024013114272464000_bib34","first-page":"S162","article-title":"Inefficacy of the 50 units nasal spray of salmon calcitonin in patients after oophorectomy (abstract)","volume":"3","author":"Devogelaer","year":"1988","journal-title":"J Bone Min Res"},{"key":"2024013114272464000_bib35","first-page":"1861","volume-title":"Osteoporosis 1990","author":"Meunier","year":"1990"},{"key":"2024013114272464000_bib36","first-page":"455","author":"Tremolieres","year":"1990"},{"key":"2024013114272464000_bib37","first-page":"59","volume-title":"Advances in Osteoporosis. Diagnosis and Treatment Today","author":"Mazzuoli","year":"1989"},{"key":"2024013114272464000_bib38","first-page":"205","volume-title":"Calcitonin","author":"Glowacki","year":"1983"},{"key":"2024013114272464000_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/endo-123-1-159","article-title":"The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation","volume":"123","author":"Farley","year":"1988","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/BF02556040","article-title":"Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride","volume":"45","author":"Farley","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02556147","article-title":"Calcitonin has direct effects on 3[H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-line cells","volume":"48","author":"Farley","year":"1991","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0026-0495(93)90179-R","article-title":"Calcitonin acutely increases net 45Ca uptake and alters alkaline phosphatase specific activity in human osteosarcoma cells","volume":"42","author":"Farley","year":"1993","journal-title":"Metabolism"},{"key":"2024013114272464000_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00297300","article-title":"Two biochemical indices of mouse bone formation are increased, in vivo, in response to calcitonin","volume":"50","author":"Farley","year":"1992","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/09513599309152486","article-title":"Comparative effects of eel calcitonin, salmon calcitonin and [Asu1,7]eel calcitonin on hypophyseal and osteoblastic function","volume":"7","author":"Sortino","year":"1993","journal-title":"Gynecol Endocrinol"},{"key":"2024013114272464000_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF00310194","article-title":"Effects of calcitonin on bone quality and osteoblastic function","volume":"52","author":"Wallach","year":"1993","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00217561","article-title":"Immunocytochemical evidence for endogenous calcitonin and parathyroid hormone in osteoblasts from the calvaria of neonatal mice","volume":"240","author":"Morel","year":"1985","journal-title":"Cell Tissue Res"},{"key":"2024013114272464000_bib47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1083\/jcb.85.3.682","article-title":"Direct in vivo demonstration by autoradiography of specific binding sites for calcitonin in skeletal and renal tissues of the rat","volume":"85","author":"Warshawsky","year":"1980","journal-title":"J Cell Biol"},{"key":"2024013114272464000_bib48","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/endo-108-5-1972","article-title":"Immunohistochemical demonstration of calcitonin binding to specific cell types in fixed rat bone tissue","volume":"108","author":"Rao","year":"1981","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib49","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1210\/endo.130.1.1309338","article-title":"Effects of calcitonin on 3\u01d0, 5\u01d0-cyclic adenosine monophosphate and calcium second messenger generation and osteoblast function in UMR 106\u201306 osteoblast-like cells","volume":"130","author":"Iida-Klein","year":"1992","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib50","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1210\/endo-119-6-2649","article-title":"Osteoblastic insufficiency is responsible for maintenance of osteopenia after loss of ovarian function","volume":"119","author":"Malluche","year":"1986","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib51","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/endo-122-5-1998","article-title":"1,25-dihydroxyvitamin D3 corrects bone loss but suppresses bone remodeling in ovariohysterectomized beagle dogs","volume":"122","author":"Malluche","year":"1988","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jbmr.5650050310","article-title":"Bone changes occurring early after cessation of ovarian function in beagle dogs: A histomorphometric study employing sequential biopsies","volume":"5","author":"Faugere","year":"1990","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib53","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/jbmr.5650081109","article-title":"A new bisphosphonate, BM21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs","volume":"8","author":"Monier-Faugere","year":"1993","journal-title":"J Bone Min Res"},{"key":"2024013114272464000_bib54","first-page":"232","volume-title":"Fundamentals of Small Animal Surgery","author":"Leonard","year":"1968"},{"key":"2024013114272464000_bib55","volume-title":"Guide for the Care and Use of Laboratory Animals","year":"1972"},{"key":"2024013114272464000_bib56","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1988","journal-title":"Clin Chem"},{"key":"2024013114272464000_bib57","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2460\/ajvr.1989.50.07.1123","article-title":"Human-parathormone assay for use in dogs: Validation, sample handling studies, and parathyroid function testing","volume":"50","author":"Torrance","year":"1989","journal-title":"Am J Vet Res"},{"key":"2024013114272464000_bib58","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/jbmr.5650080613","article-title":"Development and characterization of a polyclonal antiserum-based radioimmunoassay for dog osteocalcin","volume":"8","author":"Fanti","year":"1993","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib59","doi-asserted-by":"crossref","DOI":"10.1159\/isbn.978-3-318-04339-6","volume-title":"Atlas of Mineralized Bone Histology","author":"Malluche","year":"1986"},{"key":"2024013114272464000_bib60","first-page":"237","article-title":"A modification of the Masson trichrome technique for routine laboratory purposes","volume":"14","author":"Goldner","year":"1938","journal-title":"Am J Pathol"},{"key":"2024013114272464000_bib61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/BF02411282","article-title":"A new semiautomatic method for quantitative static and dynamic bone histology","volume":"34","author":"Malluche","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"2024013114272464000_bib62","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units","volume":"6","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib63","first-page":"189","volume-title":"SPSS for Windows Base System User's Guide, Release 6.0","year":"1993"},{"key":"2024013114272464000_bib64","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1172\/JCI111096","article-title":"Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss","volume":"72","author":"Parfitt","year":"1983","journal-title":"J Clin Invest"},{"key":"2024013114272464000_bib65","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/bmj.295.6601.757","article-title":"Bone turnover and trabecular plate survival after artificial menopause","volume":"295","author":"Reeve","year":"1987","journal-title":"BMJ"},{"key":"2024013114272464000_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jbmr.5650010105","article-title":"A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies: Qualitative observations in normal and osteoporotic subjects","volume":"1","author":"Dempster","year":"1986","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib67","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.8480174","article-title":"Cytokines and estrogen in bone: Antiosteoporotic effects","volume":"260","author":"Horowitz","year":"1993","journal-title":"Science"},{"key":"2024013114272464000_bib68","doi-asserted-by":"crossref","first-page":"5134","DOI":"10.1073\/pnas.88.12.5134","article-title":"Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells","volume":"88","author":"Pacifici","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl 1","key":"2024013114272464000_bib69","first-page":"S158","article-title":"Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement (abstract)","volume":"9","author":"Bismar","year":"1994","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1056\/NEJM199007123230201","article-title":"Intermittent cyclical etidronate treatment of postmenopausal osteoporosis","volume":"323","author":"Watts","year":"1990","journal-title":"N Engl J Med"},{"key":"2024013114272464000_bib71","author":"Storm","year":"1990"},{"key":"2024013114272464000_bib72","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-5320(72)90017-2","article-title":"Ultrastructural effects of calcitonin on osteoclasts in tissue culture","volume":"39","author":"Kallio","year":"1972","journal-title":"J Ultrastruct Res"},{"key":"2024013114272464000_bib73","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1210\/jcem-63-5-1080","article-title":"The effect of human calcitonin on the cytoplasmic spreading of rat osteoclasts","volume":"63","author":"Chambers","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"2024013114272464000_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jbmr.5650030111","article-title":"Bone resorption by isolated chick osteoclasts in culture is stimulated by murine cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2","volume":"3","author":"de Vernejoul","year":"1988","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib75","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/jbmr.5650020512","article-title":"Biological activity of chicken calcitonin: effects on neonatal rat and embryonic chick osteoclasts","volume":"2","author":"Dempster","year":"1987","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1677\/joe.0.1150511","article-title":"A direct action of human calcitonin gene-related peptide on isolated osteoclasts","volume":"115","author":"Zaidi","year":"1987","journal-title":"J Endocrinol"},{"key":"2024013114272464000_bib77","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/jbmr.5650040219","article-title":"Bone resorption by isolated human osteoclasts in vitro: effects of calcitonin","volume":"4","author":"Murrills","year":"1989","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/8756-3282(89)90010-0","article-title":"Time course of \u201cescape\u201d from calcitonininduced inhibition of motility and resorption of disaggregated osteoclasts","volume":"10","author":"Kanehisa","year":"1989","journal-title":"Bone"},{"key":"2024013114272464000_bib79","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1177\/37.10.2778308","article-title":"Characterization of the cytoskeleton of isolated chick osteoclasts: effect of calcitonin","volume":"37","author":"Hunter","year":"1989","journal-title":"J Histochem Cytochem"},{"issue":"Suppl 1","key":"2024013114272464000_bib80","first-page":"S283","article-title":"Decreased calcitonin receptor (CTR) mRNA in mice kidney after ovariectomy (abstract)","volume":"10","author":"Lalande","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib81","first-page":"285","article-title":"Calcitonin binding sites in bone: relationships to biological response and escape","volume":"34","author":"Tashjian","year":"1978","journal-title":"Recent Prog Horm Res"},{"key":"2024013114272464000_bib82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1210\/endo-115-1-78","article-title":"Relationship between internalization and calcitonin-induced receptor loss in T47D cells","volume":"115","author":"Findlay","year":"1984","journal-title":"Endocrinology"},{"key":"2024013114272464000_bib83","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1073\/pnas.84.15.5125","article-title":"Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography","volume":"84","author":"Bouizar","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013114272464000_bib84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1677\/joe.0.0880271","article-title":"Independent down-regulation of insulin and calcitonin receptors on a human tumor cell line","volume":"88","author":"Findlay","year":"1981","journal-title":"J Endocrinol"},{"key":"2024013114272464000_bib85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1172\/JCI117634","article-title":"Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation","volume":"95","author":"Takahashi","year":"1995","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"2024013114272464000_bib86","first-page":"S298","article-title":"The mechanism of calcitonin \u201cescape\u201d in mature mouse osteoclasts (abstract)","volume":"10","author":"Wada","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib87","doi-asserted-by":"crossref","first-page":"6613","DOI":"10.1073\/pnas.88.15.6613","article-title":"Avian osteoclasts as estrogen target cells","volume":"88","author":"Oursler","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024013114272464000_bib88","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1006\/bbrc.1994.1535","article-title":"Specific binding of estrogen to osteoclast surfaces","volume":"200","author":"Brubaker","year":"1994","journal-title":"Biochem Biophys Res Comm"},{"key":"2024013114272464000_bib89","first-page":"815","article-title":"Identification of brain isoforms of the rat calcitonin receptor","volume":"7","author":"Sexton","year":"1993","journal-title":"Molecular Endocrinology"},{"key":"2024013114272464000_bib90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/jbmr.5650100110","article-title":"Calcitonin receptor isoforms in mouse and rat osteoclasts","volume":"10","author":"Ikegame","year":"1995","journal-title":"J Bone Miner Res"},{"key":"2024013114272464000_bib91","first-page":"E938","article-title":"Salmon calcitonin reduces vertebral bone loss in glucocorticoid-treated beagles","volume":"264","author":"Lyles","year":"1993","journal-title":"Am J Physiol"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.5650110405","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/11\/4\/446\/56503747\/5650110405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/11\/4\/446\/56503747\/5650110405.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:50:56Z","timestamp":1739782256000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/11\/4\/446-455\/7501317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,4,1]]},"references-count":91,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1996,4,1]]},"published-print":{"date-parts":[[1996,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.5650110405","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1996,4,1]]},"published":{"date-parts":[[1996,4,1]]}}}